United Therapeutics Corp (UTHR): Total Assets
$7.88B
As of 2025-12-31
$7.22B
As of 2026-06-30
+9.2%
3-year compound annual growth
+11.3%
5-year compound annual growth
+13.7%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.88B | +7.0% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $7.36B | +2.7% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $7.17B | +18.6% | 2025-02-26, Balance as of period end |
| 2022-12-31 | $6.04B | +16.9% | 2024-02-21, Balance as of period end |
| 2021-12-31 | $5.17B | +12.0% | 2023-02-22, Balance as of period end |
| 2020-12-31 | $4.62B | +17.9% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $3.91B | +15.1% | 2021-02-24, Balance as of period end |
| 2018-12-31 | $3.40B | +18.1% | 2020-02-26, Balance as of period end |
| 2017-12-31 | $2.88B | +23.8% | 2019-02-27, Balance as of period end |
| 2016-12-31 | $2.33B | +6.5% | 2018-02-21, Balance as of period end |
| 2015-12-31 | $2.18B | +15.9% | 2017-02-22, Balance as of period end |
| 2014-12-31 | $1.88B | -9.7% | 2016-02-25, Balance as of period end |
| 2013-12-31 | $2.09B | +28.3% | 2015-02-24, Balance as of period end |
| 2012-12-31 | $1.63B | +7.1% | 2014-02-25, Balance as of period end |
| 2011-12-31 | $1.52B | +6.0% | 2013-02-26, Balance as of period end |
| 2010-12-31 | $1.43B | +36.1% | 2012-02-28, Balance as of period end |
| 2009-12-31 | $1.05B | n/a | 2011-02-24, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| United Therapeutics Corp (UTHR) | 2025-12-31 | $7.88B | +7.0% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $7.59B | +8.7% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $3.68B | +5.1% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $4.97B | +17.1% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $8.54B | -11.5% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $19.62B | +7.7% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $11.66B | -2.9% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $3.35B | -15.5% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $13.36B | +5.9% |
Compare UTHR, BMRN, AMRX, ALNY side by side · Screen every company in Pharmaceutical Preparations ↗